Comments on: HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

Comments on: HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress https://insideout.vn/hutchmed-highlights-sovleplenib-phase-iii-eslim-01-study-and-hematological-malignancy-programs-data-to-be-presented-at-the-upcoming-eha2024-congress/ Inside Out Fri, 17 May 2024 00:00:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2